|
1
|
Karimi-Zarchi M, Mortazavizadeh SMR,
Bashardust N, Zakerian N, Zaidabadi M, Yazdian-Anari P and Teimoori
S: The clinicopathologic characteristics and 5-year survival rate
of epithelial ovarian cancer in Yazd, Iran. Electron Physician.
7:1399–1406. 2015.PubMed/NCBI
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer Statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hannibal CG, Cortes R, Engholm G and Kjaer
SK: Survival of ovarian cancer patients in Denmark: Excess
mortality risk analysis of five-year relative survival in the
period 1978–2002. Acta Obstet Gynecol Scand. 87:1353–1360. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ozols RF, Bookman MA, Connolly DC, Daly
MB, Godwin AK, Schilder RJ, Xu X and Hamilton TC: Focus on
epithelial ovarian cancer. Cancer Cell. 5:19–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chebouti I, Kasimir-Bauer S, Buderath P,
Wimberger P, Hauch S, Kimmig R and Kuhlmann JD: EMT-like
circulating tumor cells in ovarian cancer patients are enriched by
platinum-based chemotherapy. Oncotarget. 8:48820–48831. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dragomir MP, Knutsen E and Calin GA:
SnapShot: unconventional miRNA functions. Cell. 174:1038–1038.e1.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reddy KB: MicroRNA (miRNA) in cancer.
Cancer Cell Int. 15:382015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Cecco L, Bagnoli M, Canevari S,
Califano D, Perrone F, Pignata S and Mezzanzanica D: miRNA-based
signature for predicting epithelial ovarian cancer recurrence.
Transl Cancer Res 6 (S1). S232–S234. 2017. View Article : Google Scholar
|
|
10
|
Lutgendorf SK, Thaker PH, Arevalo JM,
Goodheart MJ, Slavich GM, Sood AK and Cole SW: Biobehavioral
modulation of the exosome transcriptome in ovarian carcinoma.
Cancer. 124:580–586. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thomou T, Mori MA, Dreyfuss JM, Konishi M,
Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R,
Grinspoon SK, et al: Adipose-derived circulating miRNAs regulate
gene expression in other tissues. Nature. 542:450–455. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y,
Li H, Zhu X, Yao L and Zhang J: Exosomal miR-221/222 enhances
tamoxifen resistance in recipient ER-positive breast cancer cells.
Breast Cancer Res Treat. 147:423–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan C, Stevic I, Müller V, Ni Q,
Oliveira-Ferrer L, Pantel K and Schwarzenbach H: Exosomal microRNAs
as tumor markers in epithelial ovarian cancer. Mol Oncol.
12:1935–1948. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng X, Müller V, Milde-Langosch K,
Trillsch F, Pantel K and Schwarzenbach H: Diagnostic and prognostic
relevance of circulating exosomal miR-373, miR-200a, miR-200b and
miR-200c in patients with epithelial ovarian cancer. Oncotarget.
7:16923–16935. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen
Y, Wang J, Liu Y, Chen P, Wu X, et al: Urinary microRNA-30a-5p is a
potential biomarker for ovarian serous adenocarcinoma. Oncol Rep.
33:2915–2923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corney DC, Hwang CI, Matoso A, Vogt M,
Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH,
Hermeking H, et al: Frequent downregulation of miR-34 family in
human ovarian cancers. Clin Cancer Res. 16:1119–1128. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hosseinpour Z, Salehi Z, Talesh Sasani S
and Aminian K: p53 and miR-34b/c genetic variation and their impact
on ulcerative colitis susceptibility. Br J Biomed Sci. 75:46–49.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly
KA, Calin GA, Li Z, Bast RC Jr and Le XF: Clinically relevant
microRNAs in ovarian cancer. Mol Cancer Res. 13:393–401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vogt M, Munding J, Grüner M, Liffers ST,
Verdoodt B, Hauk J, Steinstraesser L, Tannapfel A and Hermeking H:
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG
methylation in colorectal, pancreatic, mammary, ovarian,
urothelial, and renal cell carcinomas and soft tissue sarcomas.
Virchows Arch. 458:313–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chaw SY, Abdul Majeed A, Dalley AJ, Chan
A, Stein S and Farah CS: Epithelial to mesenchymal transition (EMT)
biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral
squamous cell carcinogenesis and transformation. Oral Oncol.
48:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Groeneweg JW, Foster R, Growdon WB,
Verheijen RH and Rueda BR: Notch signaling in serous ovarian
cancer. J Ovarian Res. 7:952014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang CP, Yang JL, Zhang J, Li L, Huang L,
Ji SY, Hu ZY, Gao F and Liu YX: Notch signaling is involved in
ovarian follicle development by regulating granulosa cell
proliferation. Endocrinology. 152:2437–2447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yeung TL, Leung CS, Yip KP, Au Yeung CL,
Wong ST and Mok SC: Cellular and molecular processes in ovarian
cancer metastasis. A Review in the Theme: Cell and molecular
processes in cancer metastasis. Am J Physiol Cell Physiol.
309:C444–C456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Srivastava AK, Banerjee A, Cui T, Han C,
Cai S, Liu L, Wu D, Cui R, Li Z, Zhang X, et al: Inhibition of
miR-328-3p impairs cancer stem cell function and prevents
metastasis in ovarian cancer. Cancer Res. 79:2314–2326. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao W, Han T, Li B, Ma Q, Yang P and Li
H: miR-552 promotes ovarian cancer progression by regulating PTEN
pathway. J Ovarian Res. 12:1212019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deb B, Uddin A and Chakraborty S: miRNAs
and ovarian cancer: An overview. J Cell Physiol. 233:3846–3854.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Christenson LK: MicroRNA control of
ovarian function. Anim Reprod. 7:129–133. 2010.PubMed/NCBI
|
|
30
|
Xie YL, Yang YJ, Tang C, Sheng HJ, Jiang
Y, Han K and Ding LJ: Estrogen combined with progesterone decreases
cell proliferation and inhibits the expression of Bcl-2 via
microRNA let-7a and miR-34b in ovarian cancer cells. Clin Transl
Oncol. 16:898–905. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Ying X and Wang X, Wu X, Zhu Q and
Wang X: Exosomes derived from hypoxic epithelial ovarian cancer
deliver microRNA-940 to induce macrophage M2 polarization. Oncol
Rep. 38:522–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamakuchi M and Lowenstein CJ: MiR-34,
SIRT1 and p53: The feedback loop. Cell Cycle. 8:712–715. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hiyoshi Y, Schetter AJ, Okayama H, Inamura
K, Anami K, Nguyen GH, Horikawa I, Hawkes JE, Bowman ED, Leung SY,
et al: Increased microRNA-34b and −34c predominantly expressed in
stromal tissues is associated with poor prognosis in human colon
cancer. PLoS One. 10:e01248992015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai
CH, Kao HW, Fang WL, Huang KH, Chan WC, et al: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Cheng H, Shi S, Cui X, Yang J, Chen
L, Cen P, Cai X, Lu Y, Wu C, et al: MicroRNA-34b inhibits
pancreatic cancer metastasis through repressing Smad3. Curr Mol
Med. 13:467–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chakraborty C, Sharma AR, Sharma G, Doss
CGP and Lee SS: Therapeutic miRNA and siRNA: Moving from bench to
clinic as next generation medicine. Mol Ther Nucleic Acids.
8:132–143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jung WJ, Koh Y, Kim S, Park H and Yoon SS:
Activity of microRNA replacement reagent, MRX34, in multiple
myeloma in vivo model. Cancer Res. 76:1081. 2016.
|
|
38
|
Butz H, Nofech-Mozes R, Ding Q, Khella
HWZ, Szabó PM, Jewett M, Finelli A, Lee J, Ordon M, Stewart R, et
al: Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate
Cell-Cell Communication in Renal Cell Carcinoma. Eur Urol Focus.
2:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ramezani A, Devaney JM, Cohen S, Wing MR,
Scott R, Knoblach S, Singhal R, Howard L, Kopp JB and Raj DS:
Circulating and urinary microRNA profile in focal segmental
glomerulosclerosis: A pilot study. Eur J Clin Invest. 45:394–404.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Siebel C and Lendahl U: Notch signaling in
development, tissue homeostasis, and disease. Physiol Rev.
97:1235–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiu MX and Liu YM: The role of oncogenic
Notch2 signaling in cancer: A novel therapeutic target. Am J Cancer
Res. 9:837–854. 2019.PubMed/NCBI
|
|
43
|
Koch U and Radtke F: Dual function of
notch signaling in cancer: oncogene and tumor suppressor. Targeting
Notch in Cancer. Miele L and Artavanis-Tsakonas S: Springer; New
York, NY: pp. 55–86. 2018, View Article : Google Scholar
|
|
44
|
Vanorny DA, Prasasya RD, Chalpe AJ, Kilen
SM and Mayo KE: Notch signaling regulates ovarian follicle
formation and coordinates follicular growth. Mol Endocrinol.
28:499–511. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen C, Wang X, Huang S, Wang L, Han L and
Yu S: Prognostic roles of Notch receptor mRNA expression in human
ovarian cancer. Oncotarget. 8:32731–32740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
